OpportunityTitle: Unintentional Poisoning from Prescription Drug Overdoses in Adults (R21)
AdditionalInformationOnEligibility: &#149; Eligible Organizations: Public nonprofit organizations; private nonprofit organizations; for profit organizations; small, minority, and women-owned businesses; universities; colleges; research institutions; hospitals; community-based organizations; faith-based organizations; federally recognized or state-recognized American Indian/Alaska Native tribal governments; American Indian/Alaska Native tribally designated organizations; Alaska Native health corporations; urban Indian health organizations; tribal epidemiology centers; state and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau); and political subdivisions of states (in consultation with states.)  A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.  If you are applying as a bona fide agent of a state or local government, you must provide required documentation from the state or local government as documentation of your status.  Attach this documentation behind the first page of your application form or for electronic applications, use a PDF file and attach as &#147;Other Documents&#148; and label as appropriate.
Description: This funding opportunity announcement encourages research that will build the scientific base for the prevention of unintentional poisonings from drug overdoses in the adult population (ages 15 to 64 years). It solicits proposals from organizations to conduct exploratory/developmental research that evaluates novel approaches to drug overdose prevention and addresses the NCIPC&#146;s research agenda priorities related to unintentional poisoning. In addition, this research is consistent with CDER&apos;s mission to ensure safety of pharmaceuticals and the Center&apos;s Safe Use initiative to enhance safety of marketed drugs through partnerships with the health care community. It is meant to engage professionals from a wide spectrum of disciplines in epidemiology, community medicine, pharmacology, biostatistics, public policy, public health law, justice, and behavioral and social sciences.
GrantorContactEmailDescription: CDC PGO Technical Information Management
GrantorContactText: CDC Procurement and Grants Office &lt;br/&gt;Technical Information Management  &lt;br/&gt;Phone 770-488-2700
CloseDateExplanation: Letter of Intent Receipt Date: December 21, 2009    Application Submission Receipt Date:  January 19, 2010